Advertisement

Pharmacy

Novartis Pharmaceuticals Corp. has filed suit to block Washington state’s new 340B law, arguing it conflicts with federal 340B rules and violates the U.S. Constitution. The law, which takes effect June 10, 2026, bars drug manufacturers from restricting contract pharmacy…

Strategic Insights for the C-Suite Navigating Growth, Margin, & Enterprise Transformation Our 2026 Top Ten is here! This year, we’re offering health system executives a forward-looking lens on how pharmacy is evolving into one of the most powerful, underleveraged revenue…

Cigna’s Express Scripts continued its lead in the U.S. pharmacy benefit manager market for the second year in a row, processing nearly one-third of all prescription claims, according to a March 30 report from the Drug Channels Institute. The PBM…

The U.S.-Iran war is disrupting maritime trade and pushing oil prices above $100 a barrel, putting several medications at risk of shortage due to reliance on regional production and petrochemical inputs, according to a March 30 report from The Hill.…

When health system pharmacy margins tighten, the instinct is often to look for a big problem in purchasing performance or vendor management, such as: A bad contract.A major pricing shift.A vendor failure that clearly explains what went wrong. In reality,…

Advertisement

At many health systems, pharmacy leaders are often brought into infrastructure and operational planning after key decisions have already been made — a dynamic that can create downstream challenges for workflow, safety and efficiency. For Melissa Chase, PharmD, director of…

The FDA has approved Novo Nordisk’s Awiqli (insulin icodec-abae), making it the first once-weekly basal insulin available in the U.S. for adults with Type 2 diabetes. Awiqli is indicated as an adjunct to diet and exercise and is intended to…

The FDA has granted accelerated approval to Kresladi (marnetegragene autotemcel), the first gene therapy for severe leukocyte adhesion deficiency Type 1, a rare pediatric immune disorder. Kresladi is indicated for pediatric patients with the condition caused by biallelic ITGB2 variants…

The pharmacy technician workforce is becoming more experienced and committed to the profession as a long-term career rather than a temporary stint, but compensation gaps continue to threaten retention, according to a March 26 report from Pharmacy Technician Certification Board. …

The FDA has approved a label update for Seqirus’s Flucelvax and Flucelvax Quadrivalent to include a warning about febrile seizures in young children. The new warning applies to children ages 6 months through 4 years old, according to the Flucelvax…

Advertisement